Fast Market Research

"Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends" - New Market Report

Recently published research from GlobalData, "Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends", is now available at Fast Market Research

 

Boston, MA -- (SBWIRE) -- 02/15/2013 -- GlobalData's Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends report analyzes 20 strategic deals struck by leading and promising biotech companies. The terms and strategic drivers of these deals are analyzed based on acquisition costs, strategic fit, potential revenues, competitive advantage as well as other measures to illustrate the strategies different companies are currently using to gain market share, increase shareholder value and bring innovative and life-saving products to the booming global pharmaceuticals market. This report is an essential source of information and analysis on global strategic deals involving the top players in the global pharmaceuticals market.

View Full Report Details and Table of Contents

Scope

- The report provides full details of 20 significant deals from Q3 2011 to Q3 2012 involving promising biotech companies including deal terms and payment structure. The report provides analysis of the key drivers, trends, and strategies behind deals undertaken by biotech companies across important geographic regions including the US, EU, Asia-Pacific, Brazil, Russia, India, China, and other emerging markets. The report covers the six major therapy areas of cardiovascular disease, central nervous system (CNS), diabetes and metabolic, immunology, oncology, and respiratory. The report contains expert insights on the corporate strategies of emerging biotech companies seeking competitive advantage in the pharmaceuticals marketplace.

Reasons to Get this Report

- Analyze and emulate the strategies that promising biotech companies are using to gain market share in the increasingly competitive global pharmaceuticals market.
- Understand the various factors considered when structuring deal terms in strategic acquisitions, mergers, collaborations, and licensing.
- Identify potential takeover targets and partners, thereby maximizing your opportunities for consolidation, investment, and strategic partnerships.
- Organize your sales and marketing efforts by identifying the business regions and segments to maximize opportunities for consolidation, investment and strategic partnerships.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Biotechnology research reports at Fast Market Research

You may also be interested in these related reports:

- Janssen Biotech, Inc. - Product Pipeline Review - 2012
- Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Genentech, Inc. (DNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Biogen Idec Inc. (BIIB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Alnylam Pharmaceuticals, Inc (ALNY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Marina Biotech, Inc. - Product Pipeline Review - 2012
- Johnson & Johnson (JNJ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Bayer AG (BAYN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Bristol-Myers Squibb Company (BMY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Daiichi Sankyo Company, Limited (4568) - Pharmaceuticals & Healthcare - Deals and Alliances Profile